We are live on ! Find out more
AVXL icon

Anavex Life Sciences

61 hedge funds and large institutions have $42.6M invested in Anavex Life Sciences in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

7% more capital invested

Capital invested by funds: $39.7M → $42.6M (+$2.96M)

3% more funds holding

Funds holding: 5961 (+2)

2.18% more ownership

Funds ownership: 23.35%25.52% (+2.2%)

83% less call options, than puts

Call options by funds: $384K | Put options by funds: $2.32M

Holders
61
Holders Change
+2
Holders Change %
+3.39%
% of All Funds
1.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
22
Reduced
13
Closed
7
Calls
$384K
Puts
$2.32M
Net Calls
-$1.94M
Net Calls Change
-$793K

AVXL Hedge Fund Activity: Q3 2019 in Review

61 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2019, worth a combined $42.6M — up 7.5% from $39.7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AVXL positions and 7 closed out — a net gain of 2 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.3M. The largest seller was Jane Street, exiting entirely with an estimated $480K sold.

  • 61 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2019, up from 59 in Q2 2019.
  • Funds reported $42.6M of Anavex Life Sciences stock for Q3 2019, up 7.5% quarter-over-quarter.
  • 9 funds opened new Anavex Life Sciences positions in Q3 2019 and 7 closed out, a net change of +2 holders.
  • The largest Anavex Life Sciences buyer in Q3 2019 was Vanguard Group, an estimated $1.3M added.
  • The largest Anavex Life Sciences seller in Q3 2019 was Jane Street, an estimated $480K sold.

Based on aggregated 13F filings for Q3 2019.